Single Dose Of Psilocybin Causes Long-Term Remission Of Depression In Over 50% Of Cancer Patients | Psychedelic spotlight

Great news for those researching new treatments for depression in cancer patients! Positive long-term follow-up data has just been released from Sunstone Therapies investigator-initiated Phase 2 study evaluating synthetic psilocybin COMPASS Pathways, with some rather promising results. Administration of a single 25 mg dose of psilocybin combined with psychological support resulted in 57% of patients … Read more

Researchers combine cannabis and psilocybin for medical treatments

The combination of cannabinoids and psilocybin in a single formula for the treatment of physical and mental health problems has taken one step closer to reality, as described in a product patent of a leading cannabinoid laboratory, CaaMTech. CaaMTech, based in Issaquah, Washington, less than 20 miles southeast of Seattle, is analyzing how the two … Read more